NCT04842448 Safety and Efficacy of Hyperbaric Oxygen Therapy for Long COVID Syndrome Status COMPLETED Phase PHASE2
NCT04842435 Clinical Study in the Treatment of Patients With Moderate Course of COVID-19 Status UNKNOWN Phase PHASE2/PHASE3
NCT04841759 The Effects of a Multi-factorial Rehabilitation Program for Healthcare Workers Suffering From Post-COVID-19 Fatigue Syndrome Status COMPLETED Phase NA
NCT04840992 Phase I/II Clinical Trial of Recombinant Novel Coronavirus (COVID-19) Vaccine (Adenovirus Type 5 Vector) for Inhalation Status COMPLETED Phase PHASE1/PHASE2
NCT04839965 Study of Intravenous Ampion in Adult COVID-19 Patients Requiring Supplemental Oxygen Status TERMINATED Phase PHASE2
NCT04838834 Monitoring Serologic Response to Severe Acute Respiratory Syndrome-2 (SARS-COV-2)/COVID-19 in Children Status COMPLETED Phase N/A
NCT04836780 DEXamethasone EARLY Administration in Hospitalized Patients With Covid-19 Pneumonia Status UNKNOWN Phase PHASE3
NCT04834752 Effect of H2 Receptor Antagonist and Proton Pump Inhibitor on the Positivity Rates and Clinical Outcomes of COVID-19 Status COMPLETED Phase N/A
NCT04834089 Clinical Trial for Assessment of Anti-SARS-CoV-2 Serum for Early Treatment of COVID-19 Cases Status UNKNOWN Phase PHASE1/PHASE2
NCT04833101 Study on Heterologous Prime-boost of Recombinant COVID-19 Vaccine (Ad5 Vector) and RBD-based Protein Subunit Vaccine Status COMPLETED Phase PHASE4
NCT04832919 A Nurse-Community Health Worker-Family Partnership Model: Addressing Uptake of COVID-19 Testing and Control Measures Status UNKNOWN Phase NA
NCT04832022 Longitudinal Follow-up of Patients With Chronic Inflammatory Rheumatisms (CIRs) Vaccinated Against COVID-19 Compared to Patients Refusing Vaccination Status COMPLETED Phase N/A
NCT04828772 A Study of Anticoagulation Treatment Patterns and Outcomes of Participants Hospitalized With Coronavirus Disease 2019 (COVID-19) in Japan Status COMPLETED Phase N/A
NCT04828564 Efficacy and Safety of Favipiravir and Ribavirin Formulation for Treatment of COVID-19 Status UNKNOWN Phase PHASE2/PHASE3
NCT04828161 A Dose Finding, Efficacy and Safety Study of Ensovibep (MP0420) in Ambulatory Adult Patients With Symptomatic COVID-19 Status TERMINATED Phase PHASE2/PHASE3